Role of TLRs and DAMPs in allograft inflammation and transplant outcomes

Nature Reviews Nephrology

Volumn 12, Issue 5, 2016, Pages 281-290

  Braza, Faouzi ^a   Brouard, Sophie ^b   Chadban, Steve ^c,d   Goldstein, Daniel R ^e  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL FACTOR; DAMAGE ASSOCIATED MOLECULAR PATTERN; HYALURONIC ACID; INFLAMMASOME; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; HIGH MOBILITY GROUP B1 PROTEIN;

ACUTE GRAFT REJECTION; ALLOGRAFT; CHRONIC GRAFT REJECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HOST RESISTANCE; HUMAN; INFLAMMATION; INNATE IMMUNITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION; REVIEW; ADVERSE EFFECTS; ANIMAL; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ALLOGRAFTS; ANIMALS; HMGB1 PROTEIN; HUMANS; HYALURONIC ACID; IMMUNITY, INNATE; INFLAMMATION; MYELOID DIFFERENTIATION FACTOR 88; ORGAN TRANSPLANTATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84961864529     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2016.41     Document Type: Review

References (125)

1. Wu, H., & Chadban, S. J. Roles of Toll-like receptors in transplantation. Curr. Opin. Organ Transplant. 19, 1-7 (2014
2. Mori, D. N., Kreisel, D., Fullerton, J. N., Gilroy, D. W., & Goldstein, D. R. Inflammatory triggers of acute rejection of organ allografts. Immunol. Rev. 258, 132-144 (2014
3. Chong, A., & Alegre, M. The impact of infection and tissue damage in solid-organ transplantation. Nat. Rev. Immunol. 12, 459-471 (2012
4. McFarland-Mancini M. M., et al. Differences in wound healing in mice with deficiency of IL 6 versus IL 6 receptor. J. Immunol. 184, 7219-7228 (2010
5. Cameron G. D., et al. Haptoglobin phenotype correlates with development of cardiac transplant vasculopathy. J. Heart Lung Transplant. 23, 43-49 (2004
6. Shirali, A., & Goldstein, D. Tracking the toll of kidney disease. J. Am. Soc. Nephrol. 19, 1444-1450 (2008
7. Shirali, A., & Goldstein, D. R. Activation of the innate immune system by the endogenous ligand hyaluronan. Curr. Opin. Organ Transplant. 13, 20-25 (2008
8. Chen, G. Y., & Nuñez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837 (2010
9. Gjertson D. Impact of delayed graft function and acute rejection on kidney graft survival. Clin. Transpl. 467-480 2000
10. Debout A., et al. Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int. 87, 343-349 (2015
11. Stehlik J., et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011. J. Heart Lung Transplant. 30, 1078-1094 (2011
12. Lund L. H., et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report-focus theme: early graft failure. J. Heart Lung Transplant. 34, 1244-1254 (2015
13. Chalasani G., et al. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J. Immunol. 172, 7813-7820 (2004
14. Ponticelli, C. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol. Dial. Transplant. 29, 1134-1140 (2014
15. Matas A. J., et al. 2202 kidney transplant recipients with 10 years of graft function: what happens next? Am. J. Trans. 8, 2410-2419 (2008
16. Floerchinger B., et al. Inflammatory immune responses in a reproducible mouse brain death model. Transpl. Immunol. 27, 25-29 (2012
17. Hoffmann S. C., et al. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 74, 916-923 (2002
18. Sheen, J. H., & Heeger, P. S. Effects of complement activation on allograft injury. Curr. Opin. Organ Transplant. 20, 468-475 (2015
19. Ali, F., Dua, A., & Cronin, D. C. Changing paradigms in organ preservation and resuscitation. Curr. Opin. Organ Transplant. 20, 152-158 (2015
20. Li W., et al. Intravital 2 photon imaging of leukocyte trafficking in beating heart. J. Clin. Invest. 122, 2499-2508 (2012
21. Pittman, K., & Kubes, P. Damage-Associated molecular patterns control neutrophil recruitment. J. Innate Immun. 5, 315-323 (2013
22. Zhuang, Q., & Lakkis, F. G. Dendritic cells and innate immunity in kidney transplantation. Kidney Int. 5, 315-3 (2015
23. Lakkis, F. G. Where is the alloimmune response initiated? Am. J. Transplant 3, 241-242 (2003
24. Tsung A., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201, 1135-1143 (2005
25. Wu H., et al. HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol. 21, 1878-1890 (2010
26. Rabadi, M. M., Ghaly, T., Goligorksy, M. S., & Ratliff, B. B. HMGB1 in renal ischemic injury. Am. J. Physiol. Renal Physiol. 303, F873-F885 (2012
27. Kamo N., et al. ASC/caspase 1/IL 1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 58, 351-362 (2013
28. Tsung A., et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 204, 2913-2923 (2007
29. Helena Erlandsson Harris, U. A. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34, 1503-1512 (2004
30. Zhang A., et al. Necrostatin 1 inhibits Hmgb1 IL 23/IL 17 pathway and attenuates cardiac ischemia reperfusion injury. Transpl. Int. 27, 1077-1085 (2014
31. Syrjälä S. O., et al. Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat. J. Heart Lung Transplant. 29, 1047-1057 (2010
32. Huang Y., et al. Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am. J. Transplant. 7, 799-808 (2007
33. Moser B., et al. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am. J. Transplant. 7, 293-302 (2007
34. Dessing M. C., et al. RAGE does not contribute to renal injury and damage upon ischemia/reperfusion-induced injury. J. Innate Immun. 4, 80-85 (2012
35. Li J. H., et al. Blockade of extracellular HMGB1 suppresses xenoreactive B cell responses and delays acute vascular xenogeneic rejection. Am. J. Transplant. 15, 2062-2074 (2015
36. Zou H., et al. HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs. Am. J. Transplant. 14, 1765-1777 (2014
37. Hausenloy, D. J., & Yellon, D. M. Ischaemic conditioning and reperfusion injury. Nat. Rev. Cardiol. http://dx.doi.org/10.1038/nrcardio.2016.5 (2016
38. Wu, H., et al. Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice. Kidney Int. 85, 824-832 (2014
39. Netea, Mihai, G., Quintin, J., & van der Meer, Jos, W. M. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355-361 (2011
40. Jiang D., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173-1179 (2005
41. Teder P., et al. Resolution of lung inflammation by CD44. Science 296, 155-158 (2002
42. Noble, P. W., McKee, C. M., Cowman, M., & Shin, H. S. Hyaluronan fragments activate an NF ?B/I ?Bα autoregulatory loop in murine macrophages. J. Exp. Med. 183, 2373-2378 (1996
43. Rouschop K. M. A., et al. Protection against renal ischemia reperfusion injury by CD44 disruption. J. Am. Soc. Nephrol. 16, 2034-2043 (2005
44. Wu H., et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117, 2847-2859 (2007
45. Scheibner K. A., et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281 (2006
46. Bollyky P. L., et al. Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J. Immmunol. 179, 744-747 (2007
47. Muto J., et al. Hyaluronan digestion controls DC migration from the skin. J. Clin. Invest. 124, 1309-1319 (2014
48. Wells A., et al. Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 55, 1346-1349 (1993
49. Tesar B. M., et al. The role of hyaluronan degradation products as innate alloimmune agonists. Am. J. Transplant. 6, 2622-2635 (2006
50. Todd J. L., et al. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity. Am. J. Respir. Crit. Care Med. 189, 556-566 (2014
51. Kono, H., Chen, C. J., Ontiveros, F., & Rock, K. L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J. Clin. Invest. 120, 1939-1949 (2010
52. Shen, H., Kreisel, D., & Goldstein, D. R. Processes of sterile inflammation. J. Immunol. 191, 2857-2863 (2013
53. Oh K. H., et al. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model. Transplant Immunol. 13, 273-281 (2004
54. Tesar, B., & Goldstein, D. R. Acute allograft rejections occurs independently of inducible HSP 70. Transplantation 11, 1513-1517 (2007
55. Quaye, I. K. Haptoglobin, inflammation and disease. Trans. R. Soc. Trop. Med. Hyg. 102, 735-742 (2008
56. Shen H., et al. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J. Clin. Invest. 122, 383-387 (2012
57. Goldstein, D. R., Tesar, B. M., Akira, S., & Lakkis, F. G. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111, 1571-1578 (2003
58. Shen H., et al. Haptoglobin enhances cardiac transplant rejection. Circ. Res. 116, 1670-1679 (2015
59. Brubaker, S. W., Bonham, K. S., Zanoni, I., & Kagan, J. C. Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 33, 257-290 (2015
60. Guo, H., Callaway, J. B., & Ting, J. P. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 21, 677-687 (2015
61. Yoneyama, M., Onomoto, K., Jogi, M., Akaboshi, T., & Fujita, T. Viral RNA detection by RIG I like receptors. Curr. Opin. Immunol. 32, 48-53 (2015
62. Fitzgerald, M. E., Rawling, D. C., Vela, A., & Pyle, A. M. An evolving arsenal: viral RNA detection by RIG I like receptors. Curr. Opin. Microbiol. 20, 76-81 (2014
63. Seto T., et al. Upregulation of the apoptosis-related inflammasome in cardiac allograft rejection. J. Heart Lung Transplant. 29, 352-359 (2010
64. Shah, K. B., Mauro, A. G., Flattery, M., Toldo, S., & Abbate, A. Formation of the inflammasome during cardiac allograft rejection. Int. J. Cardiol. 201, 328-330 (2015
65. Pandey, S., Kawai, T., & Akira, S. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb. Perspect. Biol. 7, a016246 (2015
66. Takeuchi, O., & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010
67. Crellin N. K., et al. Regulation of cytokine secretion in human CD127+ LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33, 752-764 (2010
68. Leemans J. C., et al. Renal-Associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115, 2894-2903 (2005
69. Patole P. S., et al. Toll-like receptor 4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int. 68, 2582-2587 (2005
70. Leventhal, J. S., & Schroppel, B. Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int. 81, 826-832 (2012
71. Tesar, B. M., Zhang, J., Li, Q., & Goldstein, D. R. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll like receptor signal adaptor protein. Am. J. Transplant. 4, 1429-1439 (2004
72. Walker W. E., et al. Absence of innate MyD88 signaling promotes inducible allograft acceptance. J. Immunol. 177, 5307-5316 (2006
73. Wu H., et al. Absence of MyD88 signaling induces donor-specific kidney allograft tolerance. J. Am. Soc. Nephrol. 23, 1701-1716 (2012
74. Kruger B., et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl Acad. Sci. USA 106, 3390-3395 (2009
75. Pulskens W. P., et al. Toll-like receptor 4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3, e3596 (2008
76. Oberbarnscheidt M. H., et al. Non-self recognition by monocytes initiates allograft rejection. J. Clin. Invest. 124, 3579-3589 (2014
77. Chen L., et al. TLR engagement prevents transplantation tolerance. Am. J. Trans. 6, 2282-2291 (2006
78. Zhang X., et al. Induction of alloimmune tolerance in heart transplantation through gene silencing of TLR adaptors. Am. J. Trans. 12, 2675-2688 (2012
79. Kaczorowski D. J., et al. Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 87, 1455-1463 (2009
80. Wang S., et al. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88-And TRIF-dependent signaling. Dis. Model. Mech. 3, 92-103 (2010
81. Thierry A., et al. The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL 33. PLoS ONE 9, e88742 (2014
82. Ilmakunnas M., et al. High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation. Liver Transplant. 14, 1517-1525 (2008
83. Cantu E., et al. Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation. Am. J. Trans. 13, 1898-1904 (2013
84. Andrade C. F., et al. Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation. J. Heart Lung Transplant. 25, 1317-1323 (2006
85. Palmer S. M., et al. Donor polymorphisms in Toll-like receptor 4 influence the development of rejection after renal transplantation. Clin. Transplant. 20, 30-36 (2006
86. Dhillon N. et al. A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation. J. Hepatol. 53, 67-72 2010
87. Dessing M. C., et al. Intragraft Toll-like receptor profiling in acute renal allograft rejection. Nephrol. Dial. Transplant. 25, 4087-4092 (2010
88. Dessing M. C., et al. Toll-like receptor family polymorphisms are associated with primary renal diseases but not with renal outcomes following kidney transplantation. PLoS ONE 10, e0139769 (2015
89. Kuhlicke, J., Frick, J. S., Morote-Garcia, J. C., Rosenberger, P., & Eltzschig, H. K. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2, e1364 (2007
90. Powers K. A., et al. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J. Exp. Med. 203, 1951-1961 (2006
91. Zarember, K. A., & Godowski, P. J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168, 554-561 (2002
92. Calfee C. S., et al. Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J. Heart Lung Transplant. 26, 675-680 (2007
93. Oetting W. S., et al. Donor polymorphisms of toll-like receptor 4 associated with graft failure in liver transplant recipients. Liver Transpl. 18, 1399-1405 (2012
94. Kastelijn E. A., et al. Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation. J. Heart Lung Transplant. 29, 665-671 (2010
95. Ducloux D., et al. Relevance of Toll-like receptor 4 polymorphisms in renal transplantation. Kidney Int. 67, 2454-2461 (2005
96. Palmer, C., Diehn, M., Alizadeh, A. A., & Brown, P. O. Cell-Type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics 7, 115-115 (2006
97. Park, W. D., Griffin, M. D., Cornell, L. D., Cosio, F. G., & Stegall, M. D. Fibrosis with inflammation at one year predicts transplant functional decline. J. Am. Soc. Nephrol. 21, 1987-1997 (2010
98. Park, W., Griffin, M., Grande, J. P., Cosio, F., & Stegall, M. D. Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant. Transplantation 83, 1466-1476 (2007
99. Braudeau C., et al. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 86, 130-136 (2008
100. Methe, H., Zimmer, E., Grimm, C., Nabauer, M., & Koglin, J. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 78, 1324-1331 (2004
101. Naesens M., et al. Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int. 80, 1364-1376 (2011
102. Khatri P., et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J. Exp. Med. 210, 2205-2221 (2013
103. Saito T., et al. Distinct expression patterns of alveolar 'alarmins' in subtypes of chronic lung allograft dysfunction. Am. J. Trans. 14, 1425-1432 (2014
104. Chan J. K., et al. Alarmins: awaiting a clinical response. J. Clin. Invest. 122, 2711-2719 (2012
105. Eikmans, M., et al. Expression of surfactant protein C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value. J. Soc. Am. Neprol 16, 3771-3786 (2005
106. Dessing M. C., et al. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int. 87, 85-94 (2015
107. Shimizu K., et al. Loss of myeloid related protein 8/14 exacerbates cardiac allograft rejection. Circulation 124, 2920-2932 (2011
108. US National Library of Medicine ClinicalTrials.gov [online], https://www.clinicaltrials.gov/ct2/show/NCT01794663 (2013
109. US National Library of Medicine. ClinicalTrials.gov [online] https://www.clinicaltrials.gov/ct2/show/NCT01808469 (2013
110. Soares, M. P., Gozzelino, R., & Weis, S. Tissue damage control in disease tolerance. Trends Immunol. 35, 483-494 (2014
111. Anders, H. J. Immune system modulation of kidney regeneration[mdash]mechanisms and implications. Nat. Rev. Nephrol. 10, 347-358 (2014
112. Serhan, C. N., Chiang, N., & Van Dyke, T. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361 (2008
113. Kim M. G., et al. The heat-shock protein 70 induced renoprotective effect is partially mediated by CD4+CD25+Foxp3+ regulatory T cells in ischemia/reperfusion-induced acute kidney injury. Kidney Int. 85, 62-71 (2014
114. Weidemann, A., & Johnson, R. S. Biology of HIF 1α. Cell Death Differ. 15, 621-627 (2008
115. Kido M., et al. Hypoxia-inducible factor 1 alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J. Am. College Cardiol. 46, 2116-2124 (2005
116. Cai Z., et al. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF 1α. Cardiovasc. Res. 77, 463-470 (2008
117. Eltzschig, H. K., & Eckle, T. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17, 1391-1401 (2011
118. Medzhitov, R., Schneider, D. S., & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936-941 (2012
119. Chen Y., et al. Remote ischemic preconditioning fails to improve early renal function of patients undergoing living-donor renal transplantation: a randomized controlled trial. Transplantation 95, e4-6 (2013
120. Hill P., et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 19, 39-46 (2008
121. Ferenbach D. A., et al. The induction of macrophage hemeoxygenase 1 is protective during acute kidney injury in aging mice. Kidney Int. 79, 966-976 (2011
122. US National Library of Medicine ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT01430156 (2013
123. US National Library of Medicine. ClinicalTrials.gov [online] https://clinicaltrials.gov/ct2/show/NCT01920594 (2013
124. US National Library of Medicine ClinicalTrials.gov [online], https://clinicaltrials.gov/ct2/show/NCT02299661 (2014
125. Medzhitov, R., & Janeway, C. Jr. Innate immunity. N. Engl. J. Med. 343, 338-344 (2000